Caspase-1: An integral regulator of innate immunity

Seminars in Immunopathology

Volumn 37, Issue 4, 2015, Pages 419-427

  Winkler, Stefan ^a   Rösen Wolff, Angela ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Anti inflammatory; Autoinflammation; Defective; Procaspase 1; Variant

Indexed keywords

ENZYME PRECURSOR; INFLAMMASOME; INTERLEUKIN 1BETA CONVERTING ENZYME; PROCASPASE 1; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ATHEROSCLEROSIS; BURN; CELL PROTECTION; CELL SURVIVAL; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; GOUT; HUMAN; IMMUNOREGULATION; INJURY; INNATE IMMUNITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGEN CLEARANCE; PERIODIC FEVER SYNDROME; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PYROPTOSIS; RECURRENT FEVER; REVIEW; SHOCK; ANIMAL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; GENETICS; IMMUNOLOGY; IMMUNOMODULATION; INFLAMMATION; METABOLISM;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CASPASE 1; ENZYME ACTIVATION; HUMANS; IMMUNITY, INNATE; IMMUNOMODULATION; INFLAMMATION; PROTEOLYSIS;

EID: 84943580934     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-015-0494-4     Document Type: Review

References (80)

1. Chowdhury I, Tharakan B, Bhat GK (2008) Caspases—an update. Comp Biochem Physiol B Biochem Mol Biol 151:10-27. doi:10.1016/j.cbpb.2008.05.010
2. Martinon F, Mayor A, Tschopp J (2009) The inflammasomes: guardians of the body. Annu Rev Immunol 27:229-265. doi:10.1146/annurev.immunol.021908.132715
3. McIlwain DR, Berger T, Mak TW(2013) Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol 5:a008656. doi: 10.1101/cshperspect.a008656
4. Martinon F, Tschopp J (2004) Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117:561-574. doi:10.1016/j.cell.2004.05.004
5. Yazdi AS, Guarda G, D’Ombrain MC, Drexler SK (2010) Inflammatory caspases in innate immunity and inflammation. J Innate Immun 2:228-237
6. Kostura MJ, Tocci MJ, Limjuco G et al (1989) Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc Natl Acad Sci U S A 86:5227-5231
7. Black RA, Kronheim SR, Merriam JE et al (1989) A pre-aspartatespecific protease from human leukocytes that cleaves prointerleukin- 1 beta. J Biol Chem 264:5323-5326
8. Thornberry NA, Bull HG, Calaycay JR et al (1992) A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356:768-774. doi:10.1038/356768a0
9. Cerretti DP, Kozlosky CJ, Mosley B et al (1992) Molecular cloning of the interleukin-1 beta converting enzyme. Science 256:97-100
10. Walker NP, Talanian RV, Brady KD et al (1994) Crystal structure of the cysteine protease interleukin-1 beta-converting enzyme: a (p20/p10)2 homodimer. Cell 78:343-352
11. Romanowski MJ, Scheer JM, O’Brien T, McDowell RS (2004) Crystal structures of a ligand-free and malonate-bound human caspase- 1: implications for the mechanism of substrate binding. Structure 12:1361-1371. doi:10.1016/j.str.2004.05.010
12. Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10:417-426
13. Lamkanfi M, Dixit VM (2012) Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol 28:137-161. doi:10.1146/annurev-cellbio-101011-155745
14. Faustin B, Lartigue L, Bruey J-M et al (2007) Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol Cell 25:713-724. doi:10.1016/j.molcel.2007.01. 032
15. Boyden ED, Dietrich WF (2006) Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet 38:240-244. doi:10.1038/ng1724
16. Feldmeyer L, Keller M, Niklaus G et al (2007) The inflammasome mediates UVB-induced activation and secretion of interleukin- 1beta by keratinocytes. Curr Biol 17:1140-1145. doi:10.1016/j. cub.2007.05.074
17. Broderick L, De Nardo D, Franklin BS et al (2014) The inflammasome and autoinflammatory syndromes. Annu Rev Pathol 10:141125121526004. doi:10.1146/annurev-pathol- 012414-040431
18. Latz E, Xiao TS, Stutz A (2013) Activation and regulation of the inflammasomes. Nat Publ Group 13:397-411. doi:10.1038/nri3452
19. Newton, K, & Dixit, VM (2012) Signaling in innate immunity and inflammation. Cold Spring Harbor Perspectives in Biology, 4(3), pii: a006049. doi:10.1101/cshperspect.a006049
20. Bauernfeind FG, Horvath G, Stutz A et al (2009) Cutting edge: NF- κB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulatingNLRP3 expression. J Immunol 183:787-791. doi:10.4049/jimmunol.0901363
21. Fernandes-Alnemri T, Kang S, Anderson C et al (2013) Cutting edge: TLR signaling licenses IRAK1 for rapid activation of the NLRP3 inflammasome. J Immunol 191:3995-3999. doi:10.4049/jimmunol.1301681
22. Schroder K, Sagulenko V, Zamoshnikova A et al (2012) Acute lipopolysaccharide priming boosts inflammasome activation independently of inflammasome sensor induction. Immunobiology. doi: 10.1016/j.imbio.2012.07.020
23. Py BF, Kim M-S, Vakifahmetoglu-Norberg H, Yuan J (2013) Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity. Mol Cell 49:331-338. doi:10.1016/j. molcel.2012.11.009
24. Juliana C, Fernandes-Alnemri T, Kang S et al (2012) Nontranscriptional priming and deubiquitination regulate NLRP3 inflammasome activation. J Biol Chem 287:36617-36622. doi: 10.1074/jbc.M112.407130
25. Strowig T, Henao-Mejia J, Elinav E, Flavell R (2012) Inflammasomes in health and disease. Nature 481:278-286. doi: 10.1038/nature10759
26. McDermott MF, Aksentijevich I, Galon J et al (1999) Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97:133-144
27. Almeida de Jesus A, Goldbach-Mansky R (2013) Monogenic autoinflammatory diseases: concept and clinical manifestations. Clin Immunol 147:155-174. doi:10.1016/j.clim.2013.03.016
28. Hoffman HM, Mueller JL, Broide DH et al (2001) Mutation of a newgene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 29:301-305. doi:10.1038/ng756
29. Aksentijevich I, Nowak M, Mallah M et al (2002) De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrinassociated autoinflammatory diseases. Arthritis Rheum 46:3340- 3348. doi:10.1002/art.10688
30. Feldmann J, Prieur A-M, Quartier P et al (2002) Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 71:198-203
31. Masters SL, Simon A, Aksentijevich I, Kastner DL (2009) Horror autoinflammaticus: the Molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol 27:621-668. doi: 10.1146/annurev.immunol.25.022106.141627
32. Kastner DL, Aksentijevich I, Goldbach-Mansky R (2010) Autoinflammatory disease reloaded: a clinical perspective. Cell 140:784-790. doi:10.1016/j.cell.2010.03.002
33. Keller M, Rüegg A, Werner S, Beer H-D (2008) Active caspase-1 is a regulator of unconventional protein secretion. Cell 132:818-831. doi:10.1016/j.cell.2007.12.040
34. Bulau A-M, Nold MF, Li S et al (2014) Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses. Proc Natl Acad Sci U S A. doi:10.1073/pnas.1324140111
35. Gurcel L, Abrami L, Girardin S et al (2006) Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 126:1135-1145. doi:10.1016/j. cell.2006.07.033
36. Jabir MS, Ritchie ND, Li D et al (2014) Caspase-1 cleavage of the TLR adaptor TRIF inhibits autophagy and β-interferon production during Pseudomonas aeruginosa infection. Cell Host Microbe 15: 214-227. doi:10.1016/j.chom.2014.01.010
37. Madouri F, Guillou N, Fauconnier L et al (2015) Caspase-1 activation by NLRP3 inflammasome dampens IL-33-dependent house dust mite-induced allergic lung inflammation. J Mol Cell Biol. doi:10.1093/jmcb/mjv012
38. Osuka A, Hanschen M, Stoecklein V, Lederer JA (2012) A protective role for inflammasome activation following injury. Shock 37: 47-55. doi:10.1097/SHK.0b013e318234f7ff
39. Menzel CL, Sun Q, Loughran PA et al (2011) Caspase-1 is hepatoprotective during trauma and hemorrhagic shock by reducing liver injury and inflammation. Mol Med 17:1031-1038. doi:10.2119/molmed.2011.00015
40. Luksch H, Romanowski MJ, Chara O et al (2013) Naturally occurring genetic variants of human caspase-1 differ considerably in structure and the ability to activate interleukin-1β. Hum Mutat 34: 122-131. doi:10.1002/humu.22169
41. Heymann MC, Winkler S, Luksch H et al (2014) Human procaspase-1 variants with decreased enzymatic activity are associated with febrile episodes and may contribute to inflammation via RIP2 and NF-κB signaling. J Immunol 192:4379-4385. doi:10.4049/jimmunol.1203524
42. Li P (1995) Mice deficient in IL-1b-converting enzyme are defective in production of mature IL-1b and resistant to endotoxic shock. Cell 80:401-411. doi:10.1016/0092-8674(95)90490-5
43. Kuida K, Lippke JA, Ku G et al (1995) Altered cytokine export and apoptosis inmice deficient in interleukin-1 beta converting enzyme. Science 267:2000-2003
44. Zychlinsky A, Prevost MC, Sansonetti PJ (1992) Shigella flexneri induces apoptosis in infected macrophages. Nature 358:167-169. doi:10.1038/358167a0
45. Miao EA, Rajan JV, Aderem A (2011) Caspase-1-induced pyroptotic cell death. Immunol Rev 243:206-214. doi:10.1111/j. 1600-065X.2011.01044.x
46. Bergsbaken T, Fink SL, Cookson BT (2009) Pyroptosis: host cell death and inflammation. Nat Rev Microbiol 7:99-109. doi:10.1038/nrmicro2070
47. Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519-550. doi:10.1146/annurev.immunol.021908.132612
48. Miggin SM, Palsson-McDermott E, Dunne A et al (2007) NF-κB activation by the Toll-IL-1 receptor domain protein MyD88 adapter-like is regulated by caspase-1. Proc Natl Acad Sci U S A 104:3372-3377. doi:10.1073/pnas.0608100104
49. Erener S, Pétrilli V, Kassner I et al (2012) Inflammasomeactivated caspase 7 cleaves PARP1 to enhance the expression of a subset of NF-κB target genes. Mol Cell. doi:10.1016/j. molcel.2012.02.016
50. Lamkanfi M, Kalai M, Saelens X et al (2004) Caspase-1 activates nuclear factor of the kappa-enhancer in B cells independently of its enzymatic activity. J Biol Chem 279:24785-24793. doi:10.1074/jbc.M400985200
51. Kersse K, Lamkanfi M, Bertrand MJM et al (2011) Interaction patches of procaspase-1 caspase recruitment domains (CARDs) Are differently involved in procaspase-1 activation and receptorinteracting protein 2 (RIP2)-dependent nuclear factor B signaling. J Biol Chem 286:35874-35882. doi:10.1074/jbc.M111.242321
52. Sarkar A, Duncan M, Hart J et al (2006) ASC directs NF-kappaB activation by regulating receptor interacting protein-2 (RIP2) caspase-1 interactions. J Immunol 176:4979-4986
53. Broadley KN, Aquino AM, Woodward SC et al (1989) Monospecific antibodies implicate basic fibroblast growth factor in normal wound repair. Lab Investig 61:571-575
54. Kumar S, Hanning CR, Brigham-Burke MR et al (2002) Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production. Cytokine 18:61-71. doi:10.1006/cyto. 2002.0873
55. Sharma S, Kulk N, Nold MF et al (2008) The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines. J Immunol 180:5477-5482
56. Nold MF, Nold-Petry CA, Zepp JA et al (2010) IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 11:1014-1022. doi:10.1038/ni.1944
57. Moretti S, Bozza S, Oikonomou V et al (2014) IL-37 inhibits inflammasome activation and disease severity in murine aspergillosis. PLoS Pathog 10:e1004462. doi:10.1371/journal.ppat. 1004462
58. Mao K, Chen S, Chen M et al (2013) Nitric oxide suppresses NLRP3 inflammasome activation and protects against LPSinduced septic shock. Cell Res 23:201-212. doi:10.1038/cr. 2013.6
59. Koizumi Y, Toma C, Higa N et al (2011) Inflammasome activation via intracellular NLRs triggered by bacterial infection. Cell Microbiol 14:149-154. doi:10.1111/j.1462-5822.2011.01707.x
60. Goldstein JL, DeBose-Boyd RA, Brown MS(2006) Protein sensors for membrane sterols. Cell 124:35-46. doi:10.1016/j.cell.2005.12. 022
61. Aries A, Whitcomb J, Shao Wet al (2014) Caspase-1 cleavage of transcription factor GATA4 and regulation of cardiac cell fate. Cell Death Dis 5:e1566. doi:10.1038/cddis.2014.524
62. Deretic V, Levine B (2009) Autophagy, immunity, and microbial adaptations. Cell Host Microbe 5:527-549. doi:10.1016/j.chom. 2009.05.016
63. Baehrecke EH (2005) Autophagy: dual roles in life and death? Nat Rev Mol Cell Biol 6:505. doi:10.1038/nrm1666
64. Rebsamen M, Meylan E, Curran J, Tschopp J (2008) The antiviral adaptor proteins Cardif and Trif are processed and inactivated by caspases. Cell Death Differ 15:1804-1811. doi:10.1038/cdd.2008. 119
65. Kayagaki N, Warming S, Lamkanfi M et al (2011) Non-canonical inflammasome activation targets caspase-11. Nature 479:117-121. doi:10.1038/nature10558
66. Rathinam VAK, Vanaja SK, Waggoner L et al (2012) TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gramnegative bacteria. Cell 150:606-619. doi:10.1016/j.cell.2012.07. 007
67. Gurung P, Malireddi RKS, Anand PK et al (2012) Toll or interleukin-1 receptor (TIR) domain-containing adaptor inducing interferon-β (TRIF)-mediated caspase-11 protease production integrates Toll-like receptor 4 (TLR4) protein- and Nlrp3 inflammasome-mediated host defense against enteropathogens. J Biol Chem 287:34474-34483. doi:10.1074/jbc.M112.401406
68. Henry T, Brotcke A, Weiss DS et al (2007) Type I interferon signaling is required for activation of the inflammasome during Francisella infection. J Exp Med 204:987-994. doi:10.1084/jem. 20062665
69. Makrinioti H, Toussaint M, Jackson DJ et al (2014) Role of interleukin 33 in respiratory allergy and asthma. Lancet Respir Med 2: 226-237. doi:10.1016/S2213-2600(13)70261-3
70. Pei C, Barbour M, Fairlie-Clarke KJ et al (2013) Emerging role of interleukin-33 in autoimmune diseases. Immunology 141:9-17. doi:10.1111/imm.12174
71. Kakkar R, Lee RT (2008) The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov 7:827-840. doi:10.1038/nrd2660
72. Cayrol C, Girard J-P (2009) The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci U S A 106:9021-9026. doi:10.1073/pnas.0812690106
73. Kool M, Willart MAM, van Nimwegen M et al (2011) An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma. Immunity 34:527-540. doi:10.1016/j.immuni.2011.03.015
74. Hoffmann A, Baltimore D (2006) Circuitry of nuclear factor kappaB signaling. Immunol Rev 210:171-186. doi:10.1111/j. 0105-2896.2006.00375.x
75. Ogura Y, Inohara N, Benito A et al (2001) Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NFkappaB. J Biol Chem 276:4812-4818. doi:10.1074/jbc. M008072200
76. Mariathasan S, Newton K, Monack DM et al (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430:213-218. doi:10.1038/nature02664
77. Groß O, Yazdi AS, Thomas CJ et al (2012) Inflammasome activators induce interleukin-1α secretion via distinct pathways with differential requirement for the protease function of caspase-1. Immunity 36:388-400. doi:10.1016/j.immuni.2012.01.018
78. Broz P, von Moltke J, Jones JW et al (2010) Differential requirement for Caspase-1 autoproteolysis in pathogen-induced cell death and cytokine processing. Cell Host Microbe 8:471-483. doi:10.1016/j.chom.2010.11.007
79. Guey B, Bodnar M, Manié SN et al (2014) Caspase-1 autoproteolysis is differentially required for NLRP1b and NLRP3 inflammasome function. Proc Natl Acad Sci U S A 111:17254- 17259. doi:10.1073/pnas.1415756111
80. Van Opdenbosch N, Gurung P, Vande Walle L et al (2014) Activation of the NLRP1b inflammasome independently of ASCmediated caspase-1 autoproteolysis and speck formation. Nat Commun 5:3209. doi:10.1038/ncomms4209